The pharmaceutical goods market in El Salvador stood at 24.576 million USD in 2023, displaying a steady decline from previous years. From 2013 to 2023, the market underwent fluctuations, with significant dips in 2015-2017 and a brief recovery in 2018. The once positive compound annual growth rate (CAGR) from 2014 became negative over the last five years by -1.14%. The recent two years reflected a slight dip with a year-on-year decrease of 0.67% in 2023.
Future trends to watch for in this market include technological advancements in pharmaceuticals, the impact of healthcare policies in El Salvador, and the influence of global pharmaceutical companies on local markets. Additionally, the growth of generic drug usage and potential economic fluctuations might also play a significant role.
| # | 41 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 3,945,000,000 | 2023 | +1.25% | +1.12% | View data |
| 2 | 2 Germany | 3,201,100,000 | 2023 | -1.13% | -2.07% | View data |
| 3 | 3 France | 2,232,000,000 | 2023 | -2.43% | -2.05% | View data |
| 4 | 4 Italy | 1,865,500,000 | 2023 | -1.63% | -2.55% | View data |
| 5 | 5 United Kingdom | 1,766,700,000 | 2023 | -1.52% | -0.63% | View data |
| 34 | 34 Lithuania | 68,306,000 | 2023 | +3.68% | +4.06% | View data |
| 35 | 35 Nicaragua | 30,404,000 | 2023 | +1.73% | +1.66% | View data |
| 36 | 36 El Salvador | 24,576,000 | 2023 | -0.67% | -1.14% | |
| 37 | 37 Estonia | 14,698,000 | 2023 | -9.87% | -7.76% | View data |
| 38 | 38 Jamaica | 14,477,000 | 2023 | +1.66% | +1.62% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
